uracil has been researched along with Coronary Artery Stenosis in 1 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Excerpt | Relevance | Reference |
|---|---|---|
| " Patients with type 2 diabetes who have intermediate coronary artery stenosis (diameter stenosis <70%) as evaluated by CCTA will be treated with 25mg/day of alogliptin." | 3.85 | Effects of alogliptin on fractional flow reserve evaluated by coronary computed tomography angiography in patients with type 2 diabetes: Rationale and design of the TRACT study. ( Fukui, K; Hibi, K; Kishi, S; Michishita, I; Nozue, T; Sozu, T; Takamura, T, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nozue, T | 1 |
| Fukui, K | 1 |
| Takamura, T | 1 |
| Sozu, T | 1 |
| Hibi, K | 1 |
| Kishi, S | 1 |
| Michishita, I | 1 |
1 other study available for uracil and Coronary Artery Stenosis
| Article | Year |
|---|---|
Effects of alogliptin on fractional flow reserve evaluated by coronary computed tomography angiography in patients with type 2 diabetes: Rationale and design of the TRACT study.
Topics: Aged; Carotid Intima-Media Thickness; Computed Tomography Angiography; Coronary Angiography; Coronar | 2017 |